Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Farmers Insurance
US Department of Justice
Cantor Fitzgerald

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205342

« Back to Dashboard

NDA 205342 describes FLURANDRENOLIDE, which is a drug marketed by Cintex Svcs, Alpharma Us Pharms, Perrigo Uk Finco, and Teligent Pharma Inc, and is included in five NDAs. It is available from four suppliers. Additional details are available on the FLURANDRENOLIDE profile page.

The generic ingredient in FLURANDRENOLIDE is flurandrenolide. There are four drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the flurandrenolide profile page.

Summary for 205342

Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details

Pharmacology for NDA: 205342

Suppliers and Packaging for NDA: 205342

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FLURANDRENOLIDE flurandrenolide CREAM;TOPICAL 205342 ANDA Cintex Services, LLC 24470-919 24470-919-60 60 g in 1 TUBE (24470-919-60)
FLURANDRENOLIDE flurandrenolide CREAM;TOPICAL 205342 ANDA Cintex Services, LLC 24470-919 24470-919-12 2 TUBE in 1 CARTON (24470-919-12) > 60 g in 1 TUBE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength0.05%
Approval Date:Apr 13, 2016TE:ATRLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Queensland Health
Boehringer Ingelheim
Fish and Richardson
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: